These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Long-term survival of childhood coronary artery disease in a patient severely affected with familial hypercholesterolemia. Sibley C; McGann S; Stone NJ Am J Cardiol; 2004 Sep; 94(5):699-700. PubMed ID: 15342318 [TBL] [Abstract][Full Text] [Related]
45. [What is your diagnosis? Migrating joint swelling and enthesiopathy in hyperlipoproteinemia type II a]. Rüdt R Schweiz Rundsch Med Prax; 1991 Aug; 80(34):845-6. PubMed ID: 1925191 [No Abstract] [Full Text] [Related]
46. [A case of familial type IIa hyperlipoproteinemia with the clinical features similar to cerebrotendinous xanthomatosis]. Imasato M; Uozumi T; Tsuji S; Murai Y; Nakajima Y Rinsho Shinkeigaku; 1987 Jul; 27(7):873-6. PubMed ID: 3665278 [No Abstract] [Full Text] [Related]
47. [Acute pancreatitis in type III hyperlipoproteinemia]. Feussner G Internist (Berl); 1987 Jun; 28(6):393-5. PubMed ID: 3301725 [No Abstract] [Full Text] [Related]
48. Musculoskeletal manifestations in patients with hypercholesterolemia. Wysenbeek AJ; Shani E; Beigel Y J Rheumatol; 1989 May; 16(5):643-5. PubMed ID: 2754668 [TBL] [Abstract][Full Text] [Related]
49. [Lipid metabolism disorders--diagnosis and therapy in general practice. 1: Hypercholesterolemia]. Richter WO Fortschr Med; 1996 Apr; 114(11):133-4. PubMed ID: 8682426 [No Abstract] [Full Text] [Related]
50. Successful living-related liver transplantation for familial hypercholesterolemia in the Middle East. Khalifeh M; Faraj W; Heaton N; Rela M; Sharara AI Transpl Int; 2005 Jan; 17(11):735-9. PubMed ID: 15717219 [TBL] [Abstract][Full Text] [Related]
52. Clinical features of type III hyperlipoproteinaemia. Stuyt PM; Van 't Laar A Neth J Med; 1983; 26(4):104-11. PubMed ID: 6855990 [No Abstract] [Full Text] [Related]
53. Metabolic syndrome and risk of coronary, cerebral, and peripheral vascular disease in a large Dutch population with familial hypercholesterolemia. Rana JS; Jansen AC; Zwinderman AH; Nieuwdorp M; van Aalst-Cohen ES; Jukema JW; Trip MD; Kastelein JJ Diabetes Care; 2006 May; 29(5):1125-7. PubMed ID: 16644652 [No Abstract] [Full Text] [Related]
54. Pseudo-homozygous type IIa hypercholesterolemia. Gupta M; Sharma RB; Parakh M Indian Pediatr; 1997 Aug; 34(8):734-7. PubMed ID: 9492405 [No Abstract] [Full Text] [Related]
55. [A case of familial type IIa hypercholesterolemia with the clinical features similar to cerebrotendinous xanthomatosis]. Sakae N; Taniwaki T; Arakawa K; Yamada T; Kira J Rinsho Shinkeigaku; 2000 Mar; 40(3):222-6. PubMed ID: 10885331 [TBL] [Abstract][Full Text] [Related]
57. [Familial hypercholesterolemia in eastern Quebec: a public health problem? The experience of the hyperlipidemia clinic of Chicoutimi]. Gaudet D; Tremblay G; Perron P; Gagné C; Ouadahi Y; Moorjani S Union Med Can; 1995 Sep; 124(2):54-60. PubMed ID: 8846258 [No Abstract] [Full Text] [Related]
58. [Results of 6 months, therapy of familial hypercholesterolemia (hyperlipoproteinemia type II) with colestipol]. Kuŝić M; Gavrilović M; Mihajloviĉ M; Boŝković B Srp Arh Celok Lek; 1980 Sep; 108(9):875-81. PubMed ID: 7302695 [No Abstract] [Full Text] [Related]
59. [Familial hypercholesterolemia: do we know how to diagnose it correctly?]. Soska V Vnitr Lek; 2000 Jan; 46(1):19-23. PubMed ID: 10953659 [TBL] [Abstract][Full Text] [Related]
60. [Incidence of dyslipoproteinemias in familial epilepsy]. Havlová M; Sobra J Cesk Pediatr; 1987 Dec; 42(12):707-11. PubMed ID: 3442851 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]